Arcus Biosciences Inc (RCUS)
16.91
-0.55
(-3.15%)
USD |
NYSE |
May 17, 15:41
Arcus Biosciences Price to Book Value: 2.175 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.246 |
| May 15, 2024 | 2.258 |
| May 14, 2024 | 2.201 |
| May 13, 2024 | 2.214 |
| May 10, 2024 | 2.150 |
| May 09, 2024 | 2.078 |
| May 08, 2024 | 1.963 |
| May 07, 2024 | 2.002 |
| May 06, 2024 | 2.052 |
| May 03, 2024 | 2.020 |
| May 02, 2024 | 1.994 |
| May 01, 2024 | 1.994 |
| April 30, 2024 | 1.959 |
| April 29, 2024 | 2.011 |
| April 26, 2024 | 2.000 |
| April 25, 2024 | 1.895 |
| April 24, 2024 | 1.985 |
| April 23, 2024 | 1.994 |
| April 22, 2024 | 1.888 |
| April 19, 2024 | 1.877 |
| April 18, 2024 | 1.909 |
| April 17, 2024 | 1.909 |
| April 16, 2024 | 2.042 |
| April 15, 2024 | 2.096 |
| April 12, 2024 | 2.133 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.224 |
| April 10, 2024 | 2.152 |
| April 09, 2024 | 2.245 |
| April 08, 2024 | 2.181 |
| April 05, 2024 | 2.229 |
| April 04, 2024 | 2.220 |
| April 03, 2024 | 2.274 |
| April 02, 2024 | 2.278 |
| April 01, 2024 | 2.375 |
| March 31, 2024 | |
| March 28, 2024 | 3.713 |
| March 27, 2024 | 3.582 |
| March 26, 2024 | 3.275 |
| March 25, 2024 | 3.239 |
| March 22, 2024 | 3.232 |
| March 21, 2024 | 3.391 |
| March 20, 2024 | 3.44 |
| March 19, 2024 | 3.403 |
| March 18, 2024 | 3.387 |
| March 15, 2024 | 3.733 |
| March 14, 2024 | 3.603 |
| March 13, 2024 | 3.747 |
| March 12, 2024 | 3.666 |
| March 11, 2024 | 3.739 |
| March 08, 2024 | 3.538 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.465
Minimum
Jun 26 2019
14.00
Maximum
Jun 02 2020
3.227
Average
2.703
Median
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.793 |
| Catalyst Pharmaceuticals Inc | 3.490 |
| Integra Lifesciences Holdings Corp | 0.7457 |
| Vertex Pharmaceuticals Inc | 6.195 |
| Adverum Biotechnologies Inc | 0.9326 |
Price to Book Value Related Metrics
| PS Ratio | 5.515 |
| Price | 16.91 |
| Earnings Yield | -18.39% |
| Market Cap | 1.538B |